NU 206
Alternative Names: NU206; R-Spondin-1; RSpo-1Latest Information Update: 03 Sep 2024
At a glance
- Originator Kirin Pharma Company; Nuvelo
- Developer Kyowa Kirin; Nuvelo; Oruka Therapeutics
- Class Growth factors; Proteins
- Mechanism of Action Wnt signalling pathway modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Bone disorders; Inflammatory bowel diseases; Mucositis; Rheumatoid arthritis; Stomatitis; Wounds